Abstract: Nevus spilus is a melanocytic cutaneous lesion consisting of a light brown background macule with numerous superimposed darker maculopapular speckles. Melanoma arising from a nevus spilus is rare, with less than 40 cases reported to date. The absolute risk for malignant transformation is not well defined, lacking a standardized management approach. We report a new case of melanoma arising from nevus spilus, with the additional peculiarity of multifocality. We offer our recommendations for the management of the condition.
INTRODUCTION
Nevus spilus (NS) is a relatively uncommon skin lesion found in 0.2%-2.3% of the general population. It is characterized by darkly pigmented macules and papules with background hyperpigmentation. [1] [2] [3] [4] [5] Despite the reports of melanoma arising within NS, the malignant potential of this entity remains unclear. 1 We report the case of a patient who presented with synchronous melanomas arising from NS.
CASE REPORT
An 83-year-old Caucasian male was referred to our department for evaluation of a recent change in a pre-existing NS on his right upper extremity. The patient reported that the lesion was present since birth and had showed no significant changes until a year before, when he noticed three darker areas showing continuous growth. He had skin phototype III and a history of significant intermittent sun exposure during childhood and early adulthood. with a medium size of 4.3 cm (± 3.5 cm). 4, 6 Spotting within the lesion is more often macular than papular, sized 1-3 mm, and develop during a period of months to years. 2, 6 NS can be divided into macu- small (<1.5 cm); medium (1.5-19.9 cm); and giant (>20 cm). [2] [3] [4] 6 Less frequent segmental/zosteriform NS has also been described. [2] [3] [4] 6 Lesions can be found anywhere on the body, but involve especially the trunk and extremities. [2] [3] [4] 6 On histology, the background pigmented lesion of NS usually corresponds to a lentigo simplex or a café au lait macule, while the dark speckles show features of a variety of nevi: junctional, compound, intradermal, dysplastic, Spitz, blue, neurotized nevus, or ink spot lentigo.
2-4,6
For a long time, NS was believed to be a harmless pigmented lesion. However, in 1957 Perkinson reported a melanoma appearing on NS for the first time.
2,4,6,7 Since then, less than 40 cases of melanoma developing within this entity have been published, sometimes with a fatal outcome. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Reviewing the published literature, most cases of malignant transformation were found in Caucasian or black patients, more frequently on the trunk (64%) than the limbs (36%), with a female-male ratio of 56:44 and a mean age of 49 years. 1, 2, 6 Melanoma on NS was usually one neoplasm, but multiple melanomas were observed within the same NS in three previous cases. 5, 6, 8 The melanoma most found was superficial spreading melanoma (68%), followed by nodular (16%) and in situ melanoma (16%) 2, 6 . In 60%
of cases, melanoma developed on small or medium-sized NS, 24%
on zosteriform NS, and 16% on giant NS. 2, 6 In 52% of cases, NS was present at birth; in 33%, it was acquired during infancy; and in 14%, it appeared later. 8 The exact risk for malignant degeneration within NS remains unknown 1, 4 , but it is thought to vary from 0.13%-0.2% 2, 6 . An increased risk seems to exist when the NS is congenital or acquired in infancy, of macular type, and larger than 4 cm (especially giant and zosteriform variants). 2, 4, 6, 8 Once a melanoma develops, it has a similar prognosis and management as compared with other melanomas. 6 There is no standardized management approach for NS.
Overall, patients should be advised to perform self-examination to monitor for any changes in their nevi and have a structured longterm follow-up with the help of sequential digital dermatoscopy and, if available, reflectance confocal microscopy. 1, 4, 5, 6, 9, 10 This strategy, coupled with judicious use of biopsy for suspicious areas, seems to assist in the early detection of melanoma. 1, 5, 10 Prophylactic NS excision without pathologic confirmation of dysplasia or malignancy is not supported by the available literature. 1, 2 In the setting of dysplasia or malignant melanoma, complete NS excision is reasonable, size permitting, in order to eliminate the "faulty background" and to search for any multifocal melanomas. 1, 2 NS is an entity that requires further study, in order to clarify its biologic behavior and allow future development of standardized management guidelines. To the best of our knowledge, this is the fourth report in the literature of synchronous melanomas arising within NS.q
